Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.

Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...

Outside China, the tirzepatide products are known as Mounjaro and Zepbound, respectively ... and glucagon and is also in phase 3. Shares in Eli Lilly rose sharply in pre-market trading today ...